Global Disposable Syringe Market Report: Industry Size, Segment Share and Forecast to 2034

Global Disposable Syringe Market Report: Industry Size, Segment Share and Forecast to 2034

REPORT DETAILS

Report Code: PM1563
Base Year: 2026
No. of Pages: 114
Historical Data: 2022 - 2025
Format: PDF
Published Date:
BUY NOW

Disposable Syringe Market Summary

The global disposable syringe market is estimated at USD 17.23 billion in 2026 and is projected to reach USD 18.93 billion in 2027, expanding to USD 30.26 billion by 2034 at a CAGR of 6.9% during 2027–2034. Vaccination programmes, GLP-1 and biologic injections, and safer single-use practices keep syringe volumes rising. Safety and prefillable syringes are growing fastest because they reduce needlestick injuries and dosing errors.

Market Statistics

2027 Market Estimate USD 18.93 Billion
2034 Projected Market Size USD 30.26 Billion
CAGR (2027 - 2034) 6.9%
Largest Market in 2026 North America

Key Takeaways

• The conventional disposable syringes segment holds the share an estimated 46.7% of revenue in 2026, because they are used in vaccination and routine injections worldwide.

• The safety disposable syringes segment holds the largest share by product type, an estimated 53.5% of revenue in 2026, supported by increasing adoption of needle-stick injury prevention devices.

• The hospitals and clinics segment leads by end use with an estimated 66.7% share in 2026, while home care grows with self-injected drugs.

• Glass prefillable syringe capacity is being built in the US to support biologic and GLP-1 supply.

• North America holds the largest regional share, at an estimated 37.3% in 2026, supported by biologic drug launches.

• Asia Pacific is expected to be the fastest-growing region, currently at an estimated 31.7% share, driven by vaccination programmes and local manufacturing.

• Large med-tech companies compete with Asian volume manufacturers.

Disposable syringes are disposables that are used by doctors only once to inject medicines for the treatment of diseases. These syringes are made of plastic material which is used in the field of medical and veterinary science.

These syringes are cost-effective and are ready to use in a sterilized condition that reduces the chances of contamination and spread of infection to the patient. These products are ready to use which has also helped in controlling the spread of AIDS in individuals.

Disposable Syringes Market Size

Know more about this report: Download Sample Report

The disposable syringes market is primarily driven by increasing demand for these products for giving medication through intravenous or intramuscular ways for treating the diseases. Additionally, the increase in the production of these syringes across the globe by the manufactures, and the need for controlling the cross-contamination and spread of infection also boost the industry growth during the forecast period.

The disposable syringes market is a wide industry with a huge potential owing to increasing R&D for developing new chemicals that are used in the manufacturing of these products, and continuous clinical trials to also promote the industry growth. However, increasing biologics demand would impede the industry growth during the forecast period.

Disposable Syringes Market

Know more about this report: Download Sample Report

Disposable Syringes Market Report Scope

By Type

By Application

By Region

  • Safety Syringes
  • Conventional Syringes
  • Immunization Injections
  • Therapeutic Injections
  • North America (U.S., Canada)
  • Europe (Germany, UK, France, Italy, Spain, Austria, Netherlands)
  • Asia-Pacific (China, Japan, India, Australia, South Korea, Indonesia, Thailand)
  • Latin America (Brazil, Mexico, Argentina)
  • Middle East & Africa (Israel, UAE, Saudi Arabia, South Africa)

Source: Polaris Market Research Analysis

Know more about this report: Download Sample Report

Insight by Type

Based on the therapy type the industry is segmented as safety and conventional needles. The safety segment dominated the industry in 2020 owing to the cost-effectiveness of these types as compared to conventional syringes, and rising concern for reducing the infection to the patient which in return reduces the cost of treatment.

Insight by Application

On the basis of application, the industry is segmented as immunization injections, and therapeutic injections. Therapeutic injections segment to dominate the industry over the forecast period. The growth of this segment is majorly driven by the increasing number of individuals suffering from diabetes, and other therapeutically treated diseases.

Geographic Overview

Geographically, the industry is segmented across North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is the dominating region for the disposable syringe industry followed by Europe. The major factors promoting the North American industry growth are the rising need for injectable drugs, and a large number of disposable syringes manufacturers in this region.

Similarly, the manufacturers in this region are continuously focusing on product development that has also driven the industry growth. The European disposable syringe industry is estimated to be the second most leading region. The European market hosts several headquarters of some of the key players such as Novo Nordisk, Covidien (Medtronic, Inc), B Braun, and Fresenius Kabi.

In addition, the European governments have authorized the usage of safety-engineered devices in healthcare services. Moreover, the European Pharmacopeia Convention and the U.S. Pharmacopeia Convention are two of the leading establishments that set high standards for the safety of healthcare workers, as well as patients. the European Disposable Syringe market, is estimated to generate lucrative growth opportunities during the forecast period.

Competitive Landscape

  • Kabi AG
  • Becton
  • Dickinson and Company
  • Baxter International Inc.
  • UltiMed Inc.
  • Terumo Corporation
  • Novo Nordisk
  • Henke-Sass
  • Wolf
  • Covidien
  • Braun Medical
  • Retractable Technologies

These leading players in the disposable syringe market are introducing innovative products in the market to cater to consumers. The global players are entering new markets in developing regions to expand their customer base and strengthen their market presence.

Disposable Syringe Industry Developments

  • In January 2026, BD announced a USD 110 million investment to make BD Neopak glass prefillable syringes in Columbus, Nebraska, supporting delivery of biologic and GLP-1 drugs and creating about 120 jobs. The 1 mL and 2.25 mL syringes handle high-viscosity formulations and work with autoinjectors, with supply expected from mid-2026. (Source: BD (Becton, Dickinson and Company))
  • In August 2025, BD announced a USD 35 million investment to expand prefilled flush syringe manufacturing at the same Columbus site, adding about 50 jobs. For the disposable syringe market, these investments show demand shifting toward prefilled and specialised syringes, driven by self-injected biologics and GLP-1 medicines, and toward more US-based manufacturing to strengthen supply chains. Rival syringe makers are also expanding prefillable capacity, especially for GLP-1 drugs. Demand for these drugs is expected to keep growing through 2034, supporting new investment in high-quality glass and polymer syringes. (Source: BD (Becton, Dickinson and Company))
  • In January 2026, Terumo Medical Corporation, a U.S.-based subsidiary of Japan's Terumo Corporation launched the SurTract Safety Syringe in the U.S., using SafeR passive safety technology from its Roncadelle operations. The syringe is built for increased safety during injection with passive needle-protection features to reduce the risk of occupational needlestick injuries. This trend directly supports the market for disposable syringes by introducing another safety engineered injection device and boosting competition in the premium safety syringe segment. (Source: Terumo Medical Corporation)

Disposable Syringe Market FAQ's

The disposable syringe market is valued at USD 17.23 billion in 2026 and is expected to reach USD 18.93 billion in 2027 and USD 30.26 billion by 2034, according to Polaris Market Research.

The disposable syringe market is projected to grow at a CAGR of 6.9% from 2027 to 2034, adding roughly USD 11.33 billion in value over the forecast period.

Vaccination programmes, GLP-1 and biologic injections, and safer single-use practices keep syringe volumes rising. Safety and prefillable syringes are growing fastest because they reduce needlestick injuries and dosing errors.

The main applications are immunisation, drug delivery, blood collection, and hospitals and home care. Prefilled and safety syringes for biologics and GLP-1 drugs lead growth.

Page last updated on:

  • Author:

    Shreyas Shirsat

    Senior Research Associate

    As a Senoir Research Associate, Shreyas specializes in both qualitative and quantitative research methodologies. With the academic background of medical biotechnology, Shreyas easily identifies emerging trends in healthcare domains, such as diagnostics, animal health, healthcareIT and medical devices. He emphasizes competitive landscapes, recent technology adoption, and growth opportunities in the markets. Shreyas provides detailed competitive and research analysis that supports CXOs in strategic decision-making.

    Download Sample